Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(R)-(+)-2-BENZYLOXYPROPIONIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

100836-85-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 100836-85-9 Structure
  • Basic information

    1. Product Name: (R)-(+)-2-BENZYLOXYPROPIONIC ACID
    2. Synonyms: O-BENZYL-D-LACTIC ACID;(R)-(+)-2-BENZYLOXYPROPIONIC ACID;(2R)-2-(Benzyloxy)propionic acid;(R)-2-(Benzyloxy)propanoic acid;(R)-(+)-2-(Benzyloxy)propionic acid[>=97.0% (HPLC)];(R)-(+)-O-Benzyllactic acid;Propanoic acid, 2-(phenylMethoxy)-, (2R)-
    3. CAS NO:100836-85-9
    4. Molecular Formula: C10H12O3
    5. Molecular Weight: 180.2
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 100836-85-9.mol
  • Chemical Properties

    1. Melting Point: 52-55 °C
    2. Boiling Point: 328.2°Cat760mmHg
    3. Flash Point: 130.4°C
    4. Appearance: /
    5. Density: 1.150
    6. Vapor Pressure: 7.79E-05mmHg at 25°C
    7. Refractive Index: 1.529
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. PKA: 3.57±0.10(Predicted)
    11. Water Solubility: Insoluble in water.
    12. BRN: 4675524
    13. CAS DataBase Reference: (R)-(+)-2-BENZYLOXYPROPIONIC ACID(CAS DataBase Reference)
    14. NIST Chemistry Reference: (R)-(+)-2-BENZYLOXYPROPIONIC ACID(100836-85-9)
    15. EPA Substance Registry System: (R)-(+)-2-BENZYLOXYPROPIONIC ACID(100836-85-9)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38-43
    3. Safety Statements: 26-36/37
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 100836-85-9(Hazardous Substances Data)

100836-85-9 Usage

Uses

(R)-(+)-2-Benzyloxypropionic acid is used as a pharmaceutical intermediate.

Check Digit Verification of cas no

The CAS Registry Mumber 100836-85-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,8,3 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 100836-85:
(8*1)+(7*0)+(6*0)+(5*8)+(4*3)+(3*6)+(2*8)+(1*5)=99
99 % 10 = 9
So 100836-85-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O3/c1-8(10(11)12)13-7-9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H,11,12)/t8-/m1/s1

100836-85-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L17205)  (R)-(+)-2-Benzyloxypropionic acid, 98%   

  • 100836-85-9

  • 5g

  • 378.0CNY

  • Detail
  • Alfa Aesar

  • (L17205)  (R)-(+)-2-Benzyloxypropionic acid, 98%   

  • 100836-85-9

  • 25g

  • 1344.0CNY

  • Detail
  • Alfa Aesar

  • (L17205)  (R)-(+)-2-Benzyloxypropionic acid, 98%   

  • 100836-85-9

  • 100g

  • 3848.0CNY

  • Detail
  • Sigma-Aldrich

  • (00696)  (R)-(+)-2-(Benzyloxy)propionicacid  ≥97.0% (HPLC)

  • 100836-85-9

  • 00696-25G-F

  • 3,030.30CNY

  • Detail

100836-85-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-(+)-2-BENZYLOXYPROPIONIC ACID

1.2 Other means of identification

Product number -
Other names (R)-(+)-2-Benzyloxypropionic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100836-85-9 SDS

100836-85-9Synthetic route

1,2:4,5-di-O-isopropylidene-β-D-fructopyranos-3-yl 2-(benzyloxy)propionate

1,2:4,5-di-O-isopropylidene-β-D-fructopyranos-3-yl 2-(benzyloxy)propionate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With lithium hydroxide; water In tetrahydrofuran98%
(R)-2-(benzyloxy) methyl propionate
115458-99-6

(R)-2-(benzyloxy) methyl propionate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With potassium hydroxide In methanol; water at 20℃; for 0.5h;94%
With sodium hydroxide In methanol89%
With methanol; lithium hydroxide at 20℃; for 5h;78%
C16H28O3Si2

C16H28O3Si2

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With 2,6-di-tert-butyl-pyridine; 2.6-dimethylphenol; C32H12BF24(1-)*C44H30N2O2P(1+) In toluene at -40℃; for 24h; Inert atmosphere; enantioselective reaction;86%
(S)-2-chloropropanoic acid
29617-66-1

(S)-2-chloropropanoic acid

benzyl alcohol
100-51-6

benzyl alcohol

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Stage #1: benzyl alcohol With sodium at 80 - 90℃; for 2h;
Stage #2: (S)-2-chloropropanoic acid at 55℃; for 3h;
Stage #3: With hydrogenchloride In tert-butyl methyl ether; water pH=1.5 - 6.5;
84%
(2S,4R)-3-[(R)-2-benzyloxypropanoyl]-2-trifluoromethyl-4-phenyl-1,3-oxazolidine
1220352-28-2

(2S,4R)-3-[(R)-2-benzyloxypropanoyl]-2-trifluoromethyl-4-phenyl-1,3-oxazolidine

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(2S,4R)-2-trifluoromethyl-4-phenyl-1,3-oxazolidine
203176-56-1

(2S,4R)-2-trifluoromethyl-4-phenyl-1,3-oxazolidine

Conditions
ConditionsYield
Stage #1: (2S,4R)-3-[(R)-2-benzyloxypropanoyl]-2-trifluoromethyl-4-phenyl-1,3-oxazolidine With lithium aluminium tetrahydride In diethyl ether at -10℃; for 2h; Inert atmosphere;
Stage #2: With water; sodium hydroxide In diethyl ether Inert atmosphere; Further stages;
A 82%
B 57%
C24H28N2O3

C24H28N2O3

trans-3-benzyl-3,7-diazabicyclo[4.3.0]nonan-8-one

trans-3-benzyl-3,7-diazabicyclo[4.3.0]nonan-8-one

B

2-(1-benzyl-4-(2-(benzyloxy)propanamido)piperidin-3-yl)acetic acid hydrochloride

2-(1-benzyl-4-(2-(benzyloxy)propanamido)piperidin-3-yl)acetic acid hydrochloride

C

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With water; dihydrogen peroxide; lithium hydroxide In tetrahydrofuran at 0℃; for 1.5h;A 7%
B n/a
C n/a

B

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Yield given. Yields of byproduct given;
[(4R,5S)-5-((R)-1-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy]-tert-butyl-diphenyl-silane
105544-95-4

[(4R,5S)-5-((R)-1-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy]-tert-butyl-diphenyl-silane

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multistep reaction;
Multi-step reaction with 4 steps
1: tetrabutylammonium fluoride / tetrahydrofuran / 2 h / 0 °C
2: acetic acid / H2O / 10 h / 80 °C
3: NaIO4 / acetone; H2O / 3 h / 24 °C
4: CrO3 / acetic acid; pyridine / 3 h / 23 °C
View Scheme
(2S,3R)-3-Benzyloxy-butane-1,2-diol
87604-62-4

(2S,3R)-3-Benzyloxy-butane-1,2-diol

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With ruthenium trichloride; sodium periodate In tetrachloromethane; water; acetonitrile for 2h; Ambient temperature; Yield given;
N-<(R)-α-benzyloxypropionyl>-cyclo-(β-alanylprolyl)
82939-03-5

N-<(R)-α-benzyloxypropionyl>-cyclo-(β-alanylprolyl)

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol for 5h; Ambient temperature;
L-alanin
56-41-7

L-alanin

benzyl alcohol
100-51-6

benzyl alcohol

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(S)-2-(benzyloxy)propanoic acid
33106-32-0

(S)-2-(benzyloxy)propanoic acid

Conditions
ConditionsYield
With magnesium sulfate; isopentyl nitrite for 2h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
D-Alanine
338-69-2

D-Alanine

benzyl alcohol
100-51-6

benzyl alcohol

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(S)-2-(benzyloxy)propanoic acid
33106-32-0

(S)-2-(benzyloxy)propanoic acid

Conditions
ConditionsYield
With magnesium sulfate; isopentyl nitrite for 2h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
N-(benzyloxyacetyl)-trans-2,5-bis(methoxymethoxymethyl)-pyrrolidine

N-(benzyloxyacetyl)-trans-2,5-bis(methoxymethoxymethyl)-pyrrolidine

methyl iodide
74-88-4

methyl iodide

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(S)-2-(benzyloxy)propanoic acid
33106-32-0

(S)-2-(benzyloxy)propanoic acid

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given. Title compound not separated from byproducts;
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
With chromium(VI) oxide In pyridine; acetic acid at 23℃; for 3h; Yield given;
(2R,4aR,7R,8aR)-2-((R)-1-Benzyloxy-ethyl)-4,4,7-trimethyl-hexahydro-1-oxa-3-thia-naphthalene
191982-83-9

(2R,4aR,7R,8aR)-2-((R)-1-Benzyloxy-ethyl)-4,4,7-trimethyl-hexahydro-1-oxa-3-thia-naphthalene

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(3aR,6R,7aR)-3,3,6-Trimethyl-hexahydro-benzo[d][1,2]oxathiole 2-oxide
79563-63-6

(3aR,6R,7aR)-3,3,6-Trimethyl-hexahydro-benzo[d][1,2]oxathiole 2-oxide

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogenphosphate; N-chloro-succinimide; 2-methyl-but-2-ene; silver nitrate 1) aq. CH3CN, -4 deg C, 10 min, 2) tBuOH, r.t., 20 h; Yield given. Multistep reaction;
(S)-3-(2-Benzyloxy-propionyl)-4-isopropyl-1-phenyl-imidazolidin-2-one

(S)-3-(2-Benzyloxy-propionyl)-4-isopropyl-1-phenyl-imidazolidin-2-one

A

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

B

(S)-2-(benzyloxy)propanoic acid
33106-32-0

(S)-2-(benzyloxy)propanoic acid

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water Title compound not separated from byproducts;
benzyloxyacetic acid
30379-55-6

benzyloxyacetic acid

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 78 percent / DCC; DMAP
2.1: LiHMDS / tetrahydrofuran; hexamethylphosphoric acid triamide / -78 °C
2.2: 80 percent / tetrahydrofuran; hexamethylphosphoric acid triamide / -78 °C
3.1: 98 percent / LiOH; H2O / tetrahydrofuran
View Scheme
1,2:4,5-di-O-isopropylidene-β-D-fructopyranos-3-yl benzyloxyacetate
341489-97-2

1,2:4,5-di-O-isopropylidene-β-D-fructopyranos-3-yl benzyloxyacetate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: LiHMDS / tetrahydrofuran; hexamethylphosphoric acid triamide / -78 °C
1.2: 80 percent / tetrahydrofuran; hexamethylphosphoric acid triamide / -78 °C
2.1: 98 percent / LiOH; H2O / tetrahydrofuran
View Scheme
benzyl bromide
100-39-0

benzyl bromide

potassium-compound of propionic acid-<1-methyl-2-oxo-propylidenehydrazide>

potassium-compound of propionic acid-<1-methyl-2-oxo-propylidenehydrazide>

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 80 percent / NaH / 1,2-dimethoxy-ethane
2: 89 percent / 2N NaOH / methanol
View Scheme
Multi-step reaction with 2 steps
1: 95 percent / NaH, Bu4NSO4H / tetrahydrofuran / 0.67 h / Heating
2: 1) NCS, AgNO3, 2) 2-methyl-2-butene, NaClO2, 1.6 M NaH2PO4*H2O / 1) aq. CH3CN, -4 deg C, 10 min, 2) tBuOH, r.t., 20 h
View Scheme
(2R,3R,4R)-4-Benzyloxy-pentane-1,2,3-triol

(2R,3R,4R)-4-Benzyloxy-pentane-1,2,3-triol

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaIO4 / acetone; H2O / 3 h / 24 °C
2: CrO3 / acetic acid; pyridine / 3 h / 23 °C
View Scheme
[(4R,5S)-5-((R)-1-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-methanol

[(4R,5S)-5-((R)-1-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-methanol

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid / H2O / 10 h / 80 °C
2: NaIO4 / acetone; H2O / 3 h / 24 °C
3: CrO3 / acetic acid; pyridine / 3 h / 23 °C
View Scheme
(+)-R-2-benzyloxypropionic acid chloride
82977-93-3

(+)-R-2-benzyloxypropionic acid chloride

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 0.70 g / pyridine / dioxane / 15 h / 80 °C
2: aq. HCl / methanol / 5 h / Ambient temperature
View Scheme
ethyl 2-benzyloxypropionate
2040-44-0

ethyl 2-benzyloxypropionate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent KOH / 2 h / Heating
View Scheme
benzyl alcohol
100-51-6

benzyl alcohol

BeCl2

BeCl2

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 4.5 g / Na / 5 h / Heating
2: 60 percent KOH / 2 h / Heating
View Scheme
benzoic acid
65-85-0

benzoic acid

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Ti(O-iPr)4 / CH2Cl2 / 0.5 h / Ambient temperature
2: 2percent RuCl3*5H2O, NaIO4 / acetonitrile; CCl4; H2O / 2 h / Ambient temperature
View Scheme
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: n-butyllithium; diisopropylamine / tetrahydrofuran; hexane / 1 h / -78 - 20 °C
2: 2.6-dimethylphenol; C32H12BF24(1-)*C44H30N2O2P(1+); 2,6-di-tert-butyl-pyridine / toluene / 24 h / -40 °C / Inert atmosphere
View Scheme
O-benzyl 2,2,2-trichloroacetimidate
81927-55-1

O-benzyl 2,2,2-trichloroacetimidate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trifluorormethanesulfonic acid
2: lithium hydroxide / tetrahydrofuran
View Scheme
Multi-step reaction with 2 steps
1: trifluorormethanesulfonic acid / dichloromethane; hexane / 20 °C
2: lithium hydroxide / tetrahydrofuran / 20 °C
View Scheme
benzyl bromide
100-39-0

benzyl bromide

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydride / tetrahydrofuran; N,N-dimethyl-formamide / 16 h / 75 °C
2: potassium hydroxide / water; methanol / 0.5 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: silver(l) oxide / dichloromethane / 48 h / 20 °C / Inert atmosphere
2: potassium hydroxide; water / ethanol / 0.5 h / 0 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: silver(l) oxide / tert-butyl methyl ether / 20 h / 20 °C
2: lithium hydroxide; methanol / 5 h / 20 °C
View Scheme
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-2-(benzyloxy)propan-1-ol
87037-69-2

(R)-2-(benzyloxy)propan-1-ol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 18h;100%
benzylamine hydrochloride
3287-99-8, 39110-74-2

benzylamine hydrochloride

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-N-benzyl-2-(benzyloxy)propanamide

(R)-N-benzyl-2-(benzyloxy)propanamide

Conditions
ConditionsYield
Stage #1: benzylamine hydrochloride; (R)-2-benzyloxypropionic acid With dmap; triethylamine In tetrahydrofuran for 0.5h; Inert atmosphere;
Stage #2: With 9,9-dichloro-9-silafluorene In tetrahydrofuran at 20 - 60℃; Inert atmosphere;
99%
L-proline tert-butyl ester hydrochloride
5497-76-7

L-proline tert-butyl ester hydrochloride

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(S)-1-((R)-2-Benzyloxy-propionyl)-pyrrolidine-2-carboxylic acid tert-butyl ester
203783-50-0

(S)-1-((R)-2-Benzyloxy-propionyl)-pyrrolidine-2-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; dacarbazine In tetrahydrofuran96%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(+)-R-2-benzyloxypropionic acid chloride
82977-93-3

(+)-R-2-benzyloxypropionic acid chloride

Conditions
ConditionsYield
With oxalyl dichloride at 20 - 55℃; for 2.25h;94.9%
With thionyl chloride In chloroform at 60℃; for 3h;
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 1 - 15℃; for 0.5h;
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

2-(pyridin-2-yl)isopropyl amine
52568-28-2

2-(pyridin-2-yl)isopropyl amine

C18H22N2O2

C18H22N2O2

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 16h;92%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 16h;92%
C20H38N2O5
1126974-97-7

C20H38N2O5

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

C30H48N2O7
1126975-14-1

C30H48N2O7

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane Cooling with ice; Inert atmosphere;91%
C20H38N2O5
1126975-03-8

C20H38N2O5

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

C30H48N2O7
1126975-09-4

C30H48N2O7

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; Inert atmosphere; Cooling with ice;87%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

L-phenylalanyl-α-azaproline tert-butyl ester
159174-60-4

L-phenylalanyl-α-azaproline tert-butyl ester

N-<(R)-2-benzyloxypropionyl>-L-phenylalanyl-α-azaproline tert-butyl ester
159174-59-1

N-<(R)-2-benzyloxypropionyl>-L-phenylalanyl-α-azaproline tert-butyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran; methanol 1.) 0 deg C, 4 h, 2.) 5 deg C, 16 h;86%
N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

C17H19NO3

C17H19NO3

Conditions
ConditionsYield
Stage #1: (R)-2-benzyloxypropionic acid With pivaloyl chloride; triethylamine at 0℃; for 0.5h; Inert atmosphere;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride at 20℃; for 16h; Inert atmosphere;
85%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

1-benzoyl-3-(R)-methylpiperazine
357263-39-9

1-benzoyl-3-(R)-methylpiperazine

(2R)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-benzyloxy-propan-1-one
845655-45-0

(2R)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-benzyloxy-propan-1-one

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 21h; Heating / reflux;81%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 21h; Heating / reflux;81%
4-(5-(4-chlorophenyl)-6-hydrazinyl-2-((2-methyl-6-(trifluoromethyl)-pyridin-3-yl)methyl)-3-oxo-2,3-dihydropyridazin-4-yl)-benzonitrile
1034414-82-8

4-(5-(4-chlorophenyl)-6-hydrazinyl-2-((2-methyl-6-(trifluoromethyl)-pyridin-3-yl)methyl)-3-oxo-2,3-dihydropyridazin-4-yl)-benzonitrile

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-2-(benzyloxy)-N'-(4-(4-chlorophenyl)-5-(4-cyanophenyl)-1-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-6-oxo-1,6-dihydropyridazin-3-yl)propanehydrazide
1034414-94-2

(R)-2-(benzyloxy)-N'-(4-(4-chlorophenyl)-5-(4-cyanophenyl)-1-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methyl)-6-oxo-1,6-dihydropyridazin-3-yl)propanehydrazide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 5h;76%
4-(methylsulfonyl)benzonitrile
22821-76-7

4-(methylsulfonyl)benzonitrile

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(±)-2-(benzyloxy)propanenitrile
34097-57-9

(±)-2-(benzyloxy)propanenitrile

Conditions
ConditionsYield
With riboflavin-2',3',4',5'-tetra-acetate In acetonitrile at 25℃; for 23h; Inert atmosphere; Irradiation; Sealed tube;70%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

thiosemicarbazide
79-19-6

thiosemicarbazide

5-[1-(benzyloxy)ethyl]-1,3,4-thiadiazol-2-amine

5-[1-(benzyloxy)ethyl]-1,3,4-thiadiazol-2-amine

Conditions
ConditionsYield
With trichlorophosphate In 1,4-dioxane at 80℃; for 2h;65%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

benzylamine
100-46-9

benzylamine

(R)-N-benzyl-2-(benzyloxy)propanamide

(R)-N-benzyl-2-(benzyloxy)propanamide

Conditions
ConditionsYield
With diphenylsilane In acetonitrile at 80℃; for 16h; Inert atmosphere; Sealed tube; Green chemistry;65%
L-Lactic acid
79-33-4

L-Lactic acid

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-metkyltetrahydro-2H-pyran-3-yl (S)-2-(((R)-2-(benzyloxy)propanoyl)oxy)propanoate

(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-metkyltetrahydro-2H-pyran-3-yl (S)-2-(((R)-2-(benzyloxy)propanoyl)oxy)propanoate

Conditions
ConditionsYield
Stage #1: (R)-2-benzyloxypropionic acid With 1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: L-Lactic acid In dichloromethane at 20℃; for 0.5h;
Stage #3: Zithromax(R) With 1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 4h;
64%
1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone
1300582-07-3

1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-2-(1-(benzyloxy)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one

(R)-2-(1-(benzyloxy)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
63%
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
63%
With triethylamine; HATU In dichloromethane at 20℃; for 24h;63%
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 25 - 28℃; for 24h;
60%
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone; (R)-2-benzyloxypropionic acid With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 25 - 28℃; for 24h;
60%
benzyl 4-[(2R,3S)-2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido]-5-phenylpentanoate

benzyl 4-[(2R,3S)-2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido]-5-phenylpentanoate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

benzyl 4-(3-{[2-(benzyloxy)propanoyl]oxy}-2-{[(tert-butoxy)carbonyl]amino}butanamido)-5-phenylpentanoate

benzyl 4-(3-{[2-(benzyloxy)propanoyl]oxy}-2-{[(tert-butoxy)carbonyl]amino}butanamido)-5-phenylpentanoate

Conditions
ConditionsYield
Stage #1: benzyl 4-[(2R,3S)-2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido]-5-phenylpentanoate; (R)-2-benzyloxypropionic acid With N-ethyl-N,N-diisopropylamine In dichloromethane at -20℃; for 0.25h; Inert atmosphere;
Stage #2: With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In dichloromethane at 20℃; Inert atmosphere;
63%
(+)-tert-butyl D-lactate
13650-70-9

(+)-tert-butyl D-lactate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

2-{2-(benzyloxy)-propanoyloxy}propanoic acid tert-butyl ester

2-{2-(benzyloxy)-propanoyloxy}propanoic acid tert-butyl ester

Conditions
ConditionsYield
With 2-chloro-1-methyl-pyridinium iodide; triethylamine In dichloromethane for 48h; Reflux;60%
D-lactic acid t-butyl ester
68166-83-6

D-lactic acid t-butyl ester

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

2-{2-(benzyloxy)-propanoyloxy}propanoic acid tert-butyl ester

2-{2-(benzyloxy)-propanoyloxy}propanoic acid tert-butyl ester

Conditions
ConditionsYield
With 2-chloro-1-methyl-pyridinium iodide; triethylamine In dichloromethane for 48h; Reflux;60%
benzyl 4-(2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido)butanoate

benzyl 4-(2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido)butanoate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

benzyl 4-[(2S,3R)-3-{[(2R)-2-(benzyloxy)propanoyl]oxy}-2-{[(tert-butoxy)carbonyl]amino}butanamido]butanoate

benzyl 4-[(2S,3R)-3-{[(2R)-2-(benzyloxy)propanoyl]oxy}-2-{[(tert-butoxy)carbonyl]amino}butanamido]butanoate

Conditions
ConditionsYield
Stage #1: benzyl 4-(2-{[(tert-butoxy)carbonyl]amino}-3-hydroxybutanamido)butanoate; (R)-2-benzyloxypropionic acid With N-ethyl-N,N-diisopropylamine In dichloromethane at -20℃; for 0.25h; Inert atmosphere;
Stage #2: With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In dichloromethane at 20℃; Inert atmosphere;
58%
2-(3-fluorophenyl)-1-(2-hydroxyphenyl)ethanone
1300581-93-4

2-(3-fluorophenyl)-1-(2-hydroxyphenyl)ethanone

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-2-(1-(benzyloxy)ethyl)-3-(3-fluorophenyl)-4H-chromen-4-one

(R)-2-(1-(benzyloxy)ethyl)-3-(3-fluorophenyl)-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 2-(3-fluorophenyl)-1-(2-hydroxyphenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
55%
Stage #1: 2-(3-fluorophenyl)-1-(2-hydroxyphenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
55%
Stage #1: 2-(3-fluorophenyl)-1-(2-hydroxyphenyl)ethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
55%
With triethylamine; HATU In dichloromethane at 20℃; for 24h;55%
2-(phenylsulfonyl)benzo[d]thiazole
64345-00-2

2-(phenylsulfonyl)benzo[d]thiazole

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

2-(1-(benzyloxy)ethyl)benzo[d]thiazole

2-(1-(benzyloxy)ethyl)benzo[d]thiazole

Conditions
ConditionsYield
With riboflavin tetraacetate In acetonitrile at 25℃; Sealed tube; Inert atmosphere; Irradiation;40%
butyl 2-((phenylsulfonyl)methyl)acrylate

butyl 2-((phenylsulfonyl)methyl)acrylate

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

butyl 4-(benzyloxy)-2-methylenepentanoate

butyl 4-(benzyloxy)-2-methylenepentanoate

Conditions
ConditionsYield
With riboflavin tetraacetate In acetonitrile at 25℃; for 22h; Inert atmosphere; Irradiation; Sealed tube;35%
(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl (R)-2-(benzyloxy)propanoate

(2S,3R,4S,6R)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl (R)-2-(benzyloxy)propanoate

Conditions
ConditionsYield
With 1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 19h;33%
1-(5-fluoro-2-hydroxyphenyl)-2-phenylethanone
343-59-9

1-(5-fluoro-2-hydroxyphenyl)-2-phenylethanone

(R)-2-benzyloxypropionic acid
100836-85-9

(R)-2-benzyloxypropionic acid

(R)-2-(1-(benzyloxy)ethyl)-6-fluoro-3-phenyl-4H-chromen-4-one

(R)-2-(1-(benzyloxy)ethyl)-6-fluoro-3-phenyl-4H-chromen-4-one

Conditions
ConditionsYield
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-phenylethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
19%
Stage #1: 1-(5-fluoro-2-hydroxyphenyl)-2-phenylethanone; (R)-2-benzyloxypropionic acid With HATU In dichloromethane for 0.166667h;
Stage #2: With triethylamine In dichloromethane at 20℃; for 24h;
19%
With triethylamine; HATU In dichloromethane at 20℃; for 24h;19%

100836-85-9Relevant articles and documents

Developing Pd(II) catalyzed double sp3 C-H alkoxylation for synthesis of symmetric and unsymmetric acetals

Zong, Yu,Rao, Yu

, p. 5278 - 5281 (2014)

An effective Pd(II) catalyzed double unactivated C(sp3)-H alkoxylation has been developed to prepare both symmetric and unsymmetric acetals. This new reaction demonstrates good functional group tolerance, excellent reactivity, and high yields. A variety of novel acetals can be readily accessed via this new method. (Chemical Equation Presented).

Synthesis method of (R)-2-benzyloxypropionic acid and intermediate thereof

-

Paragraph 0038-0066, (2021/08/11)

The invention relates to the technical field of organic synthesis, in particular to a synthesis method of (R)-2-benzyloxypropionic acid and an intermediate thereof. The synthesis method of the intermediate for synthesizing (R)-2-benzyloxypropionic acid comprises the step of adding sodium tert-amyl alcohol into a reaction system of R-methyl lactate and benzyl halogen. According to the synthesis method, the raw materials are easy to obtain and cheap, the production cost can be reduced, meanwhile, flammable, explosive and harmful gas cannot be formed in the reaction process, the safety risk is greatly reduced, and large-scale safety production is facilitated.

HPLC separation of 2-aryloxycarboxylic acid enantiomers on chiral stationary phases

Charushin, V. N.,Chulakov, E. N.,Krasnov, V. P.,Levit, G. L.,Sadretdinova, L. Sh.,Tumashov, A. A.,Vakarov, S. A.

, p. 900 - 907 (2021/06/07)

The possibility for separating enantiomers of a number of practically significant 2-aryloxycarboxylic acids was studied by normal- and reversed-phase HPLC on popular chiral stationary phases. The best separation parameters were achieved on the chiral phases with the polysaccharide base Chiralcel OD-H and Chiralpack AD under the normal-phase HPLC conditions. The (S)- and (R)-enantiomers of 2-(1-naphthyloxy)- and 2-(2-iodophenoxy)propionic acids with enantiomeric excess ee >99% were isolated using preparative chiral HPLC.

Casein kinase 1[epsilon] inhibitor, pharmaceutical composition and application thereof

-

Paragraph 0272; 0275, (2021/01/11)

The invention discloses a novel substituted pyrazolopyrimidine compound for inhibiting the activity of casein kinase 1[epsilon] (CK1[epsilon]), a stereoisomer or a stereoisomer mixture of the novel substituted pyrazolopyrimidine compound, a pharmaceutically acceptable salt or solvate of the novel substituted pyrazolopyrimidine compound, and application of the compound to preparation of medicine for treating diseases, disorders or symptoms benefiting from the inhibition of the activity of casein kinase 1[epsilon] (CK1[epsilon]). The compound has inhibitory activity on CK1[epsilon] kinase, OCI-LY10 cells and Karpas299 cells, shows good anti-tumor activity in an OCI-LY10 subcutaneous xenogeneic model, shows excellent synergistic anti-tumor activity when being combined with a BTK inhibitor, has good pharmacokinetic properties, and can be applied to treatment of diseases, disorders or symptoms, including cancers, autoimmune diseases and the like, which benefit from inhibition of casein kinase 1[epsilon] activity, alone or in combination with other drugs.

Acyclic 1,4-Stereocontrol via the Allylic Diazene Rearrangement: Development, Applications, and the Essential Role of Kinetic e Stereoselectivity in Tosylhydrazone Formation

Shrestha, Maha L.,Qi, Wei,McIntosh, Matthias C.

, p. 8359 - 8370 (2017/08/23)

We report full details of a method for 1,3-reductive transposition of α-alkoxy-α,β-unsaturated hydrazones to provide E-alkenes with high 1,4-stereocontrol between the two respective allylic stereocenters. The process couples a chelation-controlled reduction of the hydrazone with an in situ allylic strain controlled retro-ene reaction of an allyl diazene, i.e., an allylic diazene rearrangement. Such stereotriads are frequently observed motifs in natural products. We observed a fortuitous kinetic preference for the E-hydrazone geometry during the hydrazonation reaction, as only the E-isomers could undergo chelation-controlled reduction.

COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS

-

Page/Page column 103; 104, (2017/01/02)

The present invention relates to compositions comprising compounds for use in treating, ameliorating and/or preventing neuromuscular disorders. The compounds as defined herein preferably inhibit the ClC-1 ion channel. The invention further relates to methods of treating, preventing and/or ameliorating neuromuscular disorders, by administering said composition to a person in need thereof.

COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY

-

Paragraph 00174, (2015/10/05)

The disclosure encompasses compounds having e.g., Formula (la) or (lb), compositions thereof, and methods of modulating CFTR activity. The diclosure also encompasses methods of treating a condition associated with CFTR activity or condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a compound of Formula (I) or (lb).

Divergent Synthesis of Aeruginosins Based on a C(sp3)£H Activation Strategy

Dailler, David,Danoun, Grégory,Ourri, Benjamin,Baudoin, Olivier

, p. 9370 - 9379 (2015/06/30)

A general and scalable access to the aeruginosin family of marine natural products, exhibiting potent inhibitory activity against serine proteases, is reported. This was enabled by the strategic use of two recently implemented Pd-catalyzed C(sp3)£H activation reactions. The first method allowed us to obtain the common 2-carboxy-6-hydroxyoctahydroindole (Choi) core of the target molecules on a large scale, whereas the second method provided a rapid and divergent access to various hydroxyphenyllactic (Hpla) subunits, including halogenated ones. This unique strategy, together with an optimization of the fragment coupling sequence allowed the synthesis of four aeruginosins, that is, 98A-C and 298A from the chiral pool. Among them, aeruginosin 298A was synthesized on an unprecedentedly large scale. In addition, halogenated aeruginosins 98A and 98C were synthesized for the first time, thanks to a fine-tuning of the final hydrogenation step. Go natural! A general and scalable access to the aeruginosin family of marine natural products (see graphic), exhibiting potent inhibitory activity against serine proteases, is described. The strategic use of two different Pd-catalyzed C(sp3)£H activation reactions led to the synthesis of aeruginosins98A-C and 298A.

A general and scalable synthesis of aeruginosin marine natural products based on two strategic C(sp3)-H activation reactions

Dailler, David,Danoun, Grégory,Baudoin, Olivier

, p. 4919 - 4922 (2015/04/14)

An efficient and scalable access to the aeruginosin family of marine natural products, which exhibit potent inhibitory activity against serine proteases, is reported. This synthesis was enabled by the strategic use of two different, recently implemented C(sp3)-H activation reactions. The first method led to the common 2-carboxy-6-hydroxyoctahydroindole (Choi) core of the target molecules on a large scale, whereas the second one provided rapid and divergent access to the various hydroxyphenyllactic (Hpla) subunits. This strategy allowed the synthesis of the aeruginosins 98B and 298A, with the latter being obtained in unprecedentedly large quantities.

Catalytic enantioselective inverse electron demand hetero-diels-alder reaction with allylsilanes

Matsumura, Yuki,Suzuki, Takahiro,Sakakura, Akira,Ishihara, Kazuaki

supporting information, p. 6131 - 6134 (2014/06/23)

The first diastereo- and enantioselective inverse electron demand hetero-Diels-Alder reaction of β,γ-unsaturated α-ketoesters with allylsilanes is described. Chiral copper(II) catalysts successfully activate the β,γ-unsaturated α-ketoesters and promote the reaction with allylsilanes with excellent enantioselectivities. This process represents a new entry to chiral oxanes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100836-85-9